Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > The bottom
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(288)
•••
Comment by rad10on Aug 14, 2017 5:29am
115 Views
Post# 26577020

RE:RE:RE:The bottom

RE:RE:RE:The bottom
Flyhi2004 wrote: OK Rad...Since yur asking I want to know what the CC transcript is and can you provide a link to it or copy n paste it here....so I can review what you are referring to...

Thanks....


I'm NOT asking anything.  Suggest you do your own due diligence before spouting BS.  If you can't find the conference call there is little help for you....................

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities